Buscar
Mostrando ítems 1-10 de 28
Arrhythmias and COVID-19: A review
Current understanding of the impact of COVID-19 on arrhythmias continues to evolve as new
data emerges. Cardiac arrhythmias are more common in critically ill COVID-19 patients. The
potential mechanisms that could result ...
Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis
Background
Among many drugs that hold potential in COVID-19 pandemic, chloroquine (CQ), and its derivative hydroxychloroquine (HCQ) have generated unusual interest. With increasing usage, there has been growing concern ...
Cardiovascular drugs inducing QT prolongation: facts and evidence
(Bentham Science Publishers, 2010-01)
Acquired QT syndrome is mainly caused by the administration of drugs that prolong ventricular repolarization. On the other hand, the risk of drug-induced torsades de pointes is increased by numerous predisposing factors, ...
Síndrome de QT largo congénito: revisión de las diferentes variantes y tratamientos
(Asociación Costarricense de Cardiología, 2005)
Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation
(Springer NatureBioMed CentralBMC Cardiovascular Disorders, 2021-03-12)
Towards a new generation of dynamic indices for the assessment of drug-induced proarrhythmic risk
(RPIC, 2021)
The detection of proarrhythmic side effects in many marketed drugs has prompted the search for complementary non-invasive markers of cardiotoxicity risk. Novel indices based on the study of cardiac vector dynamics have now ...
COVID-19 infection and cardiac arrhythmias
As the coronavirus 2019 (COVID-19) pandemic marches unrelentingly, more patients with
cardiac arrhythmias are emerging due to the effects of the virus on the respiratory and cardiovascular
(CV) systems and the systemic ...